References
- LiangXYangJGaoTNasopharynx Cancer Epidemiology in ChinaChina Cancer20162511835840 Chinese
- ZongJLinSLinJImpact of intensity-modulated radiotherapy on nasopharyngeal carcinoma: validation of the 7th edition AJCC staging systemOral Oncol201551325425925467207
- GuoQPanJZongJSuggestions for lymph node classification of UICC/AJCC staging system: a retrospective study based on 1197 nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapyMedicine (Baltimore)20159420e80825997052
- HsuCLeeSHEjadiSSafety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1-positive nasopharyngeal carcinoma: results of the KEYNOTE-028 studyJ Clin Oncol201735364050405628837405
- StratiAKoutsodontisGPapaxoinisGPrognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinomaAnn Oncol20172881923193328838214
- AzourySCGilmoreRCShuklaVMolecularly targeted agents and immunotherapy for the treatment of head and neck squamous cell cancer (HNSCC)Discov Med20162111850751627448787
- WenLYouCLuXZhangLPhase II trial of concurrent chemoradiotherapy with S-1 versus weekly cisplatin for locoregionally advanced nasopharyngeal carcinomaMol Clin Oncol20153368769126137288
- WangJShiMHsiaYFailure patterns and survival in patients with nasopharyngeal carcinoma treated with intensity modulated radiation in Northwest China: a pilot studyRadiat Oncol201272922233756
- TwuCWWangWYChenCCMetronomic adjuvant chemotherapy improves treatment outcome in nasopharyngeal carcinoma patients with postradiation persistently detectable plasma Epstein-Barr virus deoxyribonucleic acidInt J Radiat Oncol Biol Phys2014891212924725686
- LiuYCWangWYTwuCWPrognostic impact of adjuvant chemotherapy in high-risk nasopharyngeal carcinoma patientsOral Oncol201764152128024719
- StocklerMRHarveyVJFrancisPACapecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancerJ Clin Oncol2011294498450422025143
- SimkensLHJTinterenHVMayAMaintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer GroupLancet201538599801843185225862517
- FengtongJJiangtaoFYatingWLiliWJianboCXiaofeiWEffects of S-1 combined with radiotherapy in the treatment of nasopharyngeal cancer: a meta-analysis based on randomized controlled trialsOpen Med (Wars)20171210711428730169
- PengPJChengHOuXQSafety and efficacy of S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy: multi-institutional retrospective analysisDrug Des Devel Ther201414810831087
- PengPJLvBJWangZHMulti-institutional prospective study of nedaplatin plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimensTher Adv Med Oncol201792687428203299
- PengPOuXLiaoHPhase II study of gemcitabine plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapyTher Adv Med Oncol20168315315927239233
- ZhangSLinSHuLLobaplatin combined with docetaxel neoadjuvant chemotherapy followed by concurrent lobaplatin with intensity-modulated radiotherapy increases the survival of patients with high-risk lymph node positive nasopharyngeal carcinomaJ BUON201621116116727061544